[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0008509A - Composição farmacêutica oral estabilizada contendo iodeto e iodato e método - Google Patents

Composição farmacêutica oral estabilizada contendo iodeto e iodato e método

Info

Publication number
BR0008509A
BR0008509A BR0008509-0A BR0008509A BR0008509A BR 0008509 A BR0008509 A BR 0008509A BR 0008509 A BR0008509 A BR 0008509A BR 0008509 A BR0008509 A BR 0008509A
Authority
BR
Brazil
Prior art keywords
iodate
pharmaceutical composition
oral pharmaceutical
composition containing
containing iodide
Prior art date
Application number
BR0008509-0A
Other languages
English (en)
Inventor
Yongjun Duan
Kirk Dinehart
John Hickey
Jack Kessler
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of BR0008509A publication Critical patent/BR0008509A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: "COMPOSIçãO FARMACêUTICA ORAL ESTABILIZADA CONTENDO IODETO E IODATO E MéTODO". Esta invenção descreve uma composição farmacêutica oral estabilizada composta de iodeto e iodato como os agentes ativos na presença de outros excipientes farmacêuticos e um método para preparar essas composições estabilizadas.
BR0008509-0A 1999-02-26 2000-02-22 Composição farmacêutica oral estabilizada contendo iodeto e iodato e método BR0008509A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/258,062 US6248335B1 (en) 1997-10-29 1999-02-26 Stabilized oral pharmaceutical composition containing iodide and iodate and method
PCT/US2000/004411 WO2000050046A1 (en) 1999-02-26 2000-02-22 Stabilized oral pharmaceutical composition containing iodide and iodate and method

Publications (1)

Publication Number Publication Date
BR0008509A true BR0008509A (pt) 2002-02-05

Family

ID=22978944

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008509-0A BR0008509A (pt) 1999-02-26 2000-02-22 Composição farmacêutica oral estabilizada contendo iodeto e iodato e método

Country Status (19)

Country Link
US (1) US6248335B1 (pt)
JP (1) JP2002537341A (pt)
KR (1) KR100674324B1 (pt)
CN (1) CN1344163A (pt)
AT (1) AT413795B (pt)
AU (1) AU778774B2 (pt)
BR (1) BR0008509A (pt)
CA (1) CA2366679C (pt)
DE (1) DE10084290T1 (pt)
DK (1) DK176595B1 (pt)
ES (1) ES2226514B2 (pt)
FI (1) FI20011703A (pt)
GB (1) GB2364641B (pt)
IL (1) IL144955A (pt)
MX (1) MXPA01008550A (pt)
NO (1) NO20014101L (pt)
SE (1) SE0102843L (pt)
WO (1) WO2000050046A1 (pt)
ZA (1) ZA200106451B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7147873B2 (en) * 2002-01-16 2006-12-12 3M Innovative Properties Company Antiseptic compositions and methods
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
CA2627154C (en) * 2004-12-24 2010-12-21 Council Of Scientific And Industrial Research An improved iodized salt and a process for its preparation
JP4885877B2 (ja) 2005-01-10 2012-02-29 セクレタリー・デパートメント・オブ・アトミック・エナジー 被影響体のインビボ環境から放射性セシウム（＊Ｃｓ）、放射性ストロンチウム（＊Ｓｒ）、および放射性ヨウ素（＊Ｉ）を同時除染する予防混合物
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
EP2830554A1 (en) 2012-03-29 2015-02-04 CXL Ophthalmics, LLC Ocular cross-linking system and method for sealing corneal wounds
ES2978927T3 (es) 2012-03-29 2024-09-23 Epion Therapeutics Inc Soluciones de tratamiento ocular, dispositivos de administración y métodos de aumento de la administración
EP2830637B1 (en) 2012-03-29 2024-08-21 Epion Therapeutics, Inc. Compositions and methods for treating or preventing diseases associated with oxidative stress
US10034899B2 (en) 2013-11-27 2018-07-31 BioPharmX, Inc. Solid oral dosage form for breast symptoms
RU2728790C2 (ru) * 2014-02-10 2020-07-31 Фред Хатчинсон Кансэр Рисёч Сентер Лечение сердечного приступа и ишемического повреждения соединениями галогена
US20170304359A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
KR102697203B1 (ko) 2016-07-21 2024-08-22 아이2퓨어 코프. 연화성 국소 소독제
US20190105344A1 (en) * 2016-09-16 2019-04-11 Jack Kessler Oral molecular iodine composition and method
WO2019237065A1 (en) * 2018-06-08 2019-12-12 Faraday Pharmaceuticals, Inc. Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486317A (en) * 1981-01-16 1984-12-04 E. I. Du Pont De Nemours And Company Stabilization of thickened aqueous fluids
RO85156B1 (ro) * 1983-05-27 1984-11-30 Institutul De Stiinte Biologice Comprimate-reactiv pentru determinarea alfa-anilazei si procedeu de obtinere a acestora
CN1036629C (zh) * 1991-03-16 1997-12-10 李克亮 动物促长剂
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
AU1693099A (en) * 1998-01-06 1999-07-26 Fujisawa Pharmaceutical Co., Ltd. Solid preparation of iodophor and its manufacturing methods
US5985340A (en) * 1998-01-19 1999-11-16 Bolentica, Inc. Method for preparing iodine supplement for animal feeds

Also Published As

Publication number Publication date
IL144955A (en) 2006-12-31
AU3371300A (en) 2000-09-14
WO2000050046A8 (en) 2003-11-27
ATA90122000A (de) 2005-10-15
MXPA01008550A (es) 2003-08-19
WO2000050046A1 (en) 2000-08-31
AT413795B (de) 2006-06-15
GB2364641A (en) 2002-02-06
KR100674324B1 (ko) 2007-01-24
KR20010103014A (ko) 2001-11-17
NO20014101L (no) 2001-10-12
IL144955A0 (en) 2002-06-30
US6248335B1 (en) 2001-06-19
DK200101258A (da) 2001-10-26
DK176595B1 (da) 2008-10-20
AU778774B2 (en) 2004-12-23
JP2002537341A (ja) 2002-11-05
FI20011703A0 (fi) 2001-08-24
ES2226514B2 (es) 2007-02-16
GB0122808D0 (en) 2001-11-14
CN1344163A (zh) 2002-04-10
DE10084290T1 (de) 2003-04-03
FI20011703A (fi) 2001-10-16
SE0102843D0 (sv) 2001-08-27
NO20014101D0 (no) 2001-08-23
GB2364641B (en) 2004-06-30
SE0102843L (sv) 2001-10-26
ZA200106451B (en) 2002-08-06
ES2226514A1 (es) 2005-03-16
CA2366679A1 (en) 2000-08-31
CA2366679C (en) 2007-05-01

Similar Documents

Publication Publication Date Title
BR0008509A (pt) Composição farmacêutica oral estabilizada contendo iodeto e iodato e método
AR023423A1 (es) Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
NO20034230L (no) 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
AR018526A1 (es) COMPOSICION FARMACEUTICA NO LIOFILIZADA EN FORMA DE SOLUCIoN QUE COMPRENDE LA HORMONA PARATIROIDEA HUMANA, PROCESO PARA PREPARA UN FRASCO O CARTUCHO QUE LA CONTIENE, PROCESO PARA PREPARAR DICHA COMPOSICIoN, FRASCO O CARTUCHO QUE CONTIENE LA COMPOSICIoN Y USO DE LA MISMA PARA LA FABRICACIoN DE UN MED
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
BR9906920A (pt) "tts contendo um antioxidante"
LU91281I2 (fr) Preotact-hormone parathyroïde
HK1113971A1 (en) Oral formulations for delivery of catecholic butanes including ndga compounds
BR9810495A (pt) Composição farmacêutica
ES2184310T3 (es) Formulacion autoemulsionante para compuestos lipofilos acidos.
AP1424A (en) 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
EE04997B1 (et) Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine
ID18079A (id) Komposisi farmasi yang mengandung bahan pemercepat osteogenesis
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
IT1302682B1 (it) Composizioni farmaceutiche orali contenenti buprenorfina
HUP0203844A2 (hu) Növekedési hormon kibocsátó tulajdonságú vegyület, ezt tartalmazó gyógyszerkészítmény és alkalmazása
ATE357928T1 (de) Pharmazeutische zusammensetzung für thrombinpeptidderivaten
ID28510A (id) Formulasi oral yang baru untuk agonis atau antagonis 5-ht4
CY1105540T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει ξανθανικο κομμι
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
UY27373A1 (es) Formulaciones de interferón beta-humano

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A E 11A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011.